Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA LE MODIFICHE in fondo alla pagina
Bicocca Open Archive
Background and objective: Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP. Methods: We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when ≥3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection. Results: Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP. Conclusion: This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.
Villafuerte, D., Aliberti, S., Soni, N., Faverio, P., Marcos, P., Wunderink, R., et al. (2020). Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. RESPIROLOGY, 25(5 (May 2020)), 543-551 [10.1111/resp.13663].
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia
Villafuerte D.;Aliberti S.;Soni N. J.;Faverio P.;Marcos P. J.;Wunderink R. G.;Rodriguez A.;Sibila O.;Sanz F.;Martin-Loeches I.;Menzella F.;Reyes L. F.;Jankovic M.;Spielmanns M.;Restrepo M. I.
;Aruj P. K.;Attorri S.;Barimboim E.;Caeiro J. P.;Garzon M. I.;Cambursano V. H.;Ceccato A.;Chertcoff J.;Cordon Diaz A.;de Vedia L.;Ganaha M. C.;Lambert S.;Lopardo G.;Luna C. M.;Malberti A. G.;Morcillo N.;Tartara S.;Pensotti C.;Pereyra B.;Scapellato P. G.;Stagnaro J. P.;Shah S.;Lotsch F.;Thalhammer F.;Anseeuw K.;Francois C. A.;Van Braeckel E.;Vincent J. L.;Djimon M. Z.;Nouer S. A.;Chipev P.;Encheva M.;Miteva D.;Petkova D.;Balkissou A. D.;Yone E. W. P.;Ngahane B. H. M.;Shen N.;Xu J. -F.;Rico C. A. B.;Buitrago R.;Paternina F. J. P.;Ntumba J. -M. K.;Carevic V. V.;Jakopovic M.;Jankovic M.;Matkovic Z.;Mitrecic I.;Jacobsson M. -L. B.;Christensen A. B.;Heitmann Bodtger U. C.;Meyer C. N.;Jensen A. V.;El-Said Abd El-Wahhab I.;Morsy N. E.;Shafiek H.;Sobh E.;Abdulsemed K. A.;Bertrand F.;Brun-Buisson C.;Montmollin E. D.;Fartoukh M.;Messika J.;Tattevin P.;Khoury A.;Ebruke B.;Dreher M.;Kolditz M.;Meisinger M.;Pletz M. W.;Hagel S.;Rupp J.;Schaberg T.;Spielmanns M.;Creutz P.;Suttorp N.;Siaw-Lartey B.;Dimakou K.;Papapetrou D.;Tsigou E.;Ampazis D.;Kaimakamis E.;Bhatia M.;Dhar R.;D'Souza G.;Garg R.;Koul P. A.;Mahesh P. A.;Jayaraj B. S.;Narayan K. V.;Udnur H. B.;Krishnamurthy S. B.;Kant S.;Swarnakar R.;Limaye S.;Salvi S.;Golshani K.;Keatings V. M.;Martin-Loeches I.;Maor Y.;Strahilevitz J.;Battaglia S.;Carrabba M.;Ceriana P.;Confalonieri M.;Monforte A. D.;Prato B. D.;Rosa M. D.;Fantini R.;Fiorentino G.;Gammino M. A.;Menzella F.;Milani G.;Nava S.;Palmiero G.;Petrino R.;Gabrielli B.;Rossi P.;Sorino C.;Steinhilber G.;Zanforlin A.;Franzetti F.;Carone M.;Patella V.;Scarlata S.;Comel A.;Kurahashi K.;Bacha Z. A.;Ugalde D. B.;Zuniga O. C.;Villegas J. F.;Medenica M.;van de Garde E. M. W.;Mihsra D. R.;Shrestha P.;Ridgeon E.;Awokola B. I.;Nwankwo O. N. O.;Olufunlola A. B.;Olumide S.;Ukwaja K. N.;Irfan M.;Minarowski L.;Szymon S.;Froes F.;Leuschner P.;Meireles M.;Ravara S. B.;Brocovschii V.;Ion C.;Rusu D.;Toma C.;Chirita D.;Dorobat C. M.;Birkun A.;Kaluzhenina A.;Almotairi A.;Bukhary Z. A. A.;Edathodu J.;Fathy A.;Enani A. M. A.;Mohamed N. E.;Memon J. U.;Bella A.;Bogdanovic N.;Milenkovic B.;Pesut D.;Borderias L.;Garcia N. M. B.;Cabello Alarcon H.;Cilloniz C.;Torres A.;Diaz-Brito V.;Casas X.;Gonzalez A. E.;Fernandez-Almira M. L.;Gallego M.;Gaspar-Garcia I.;Castillo J. G. D.;Victoria P. J.;Laserna Martinez E.;Molina R. M. D.;Marcos P. J.;Menendez R.;Pando-Sandoval A.;Aymerich C. P.;Rello J.;Moyano S.;Sanz F.;Sibila O.;Rodrigo-Troyano A.;Sole-Violan J.;Uranga A.;van Boven J. F. M.;Torra E. V.;Pujol J. A.;Feldman C.;Yum H. K.;Fiogbe A. A.;Yangui F.;Bilaceroglu S.;Dalar L.;Yilmaz U.;Bogomolov A.;Elahi N.;Dhasmana D. J.;Feneley A.;Hancock C.;Hill A. T.;Rudran B.;Ruiz-Buitrago S.;Campbell M.;Whitaker P.;Youzguin A.;Singanayagam A.;Allen K. S.;Brito V.;Dietz J.;Dysart C. E.;Kellie S. M.;Franco-Sadud R. A.;Meier G.;Gaga M.;Holland T. L.;Bergin S. P.;Kheir F.;Landmeier M.;Lois M.;Nair G. B.;Patel H.;Reyes K.;Rodriguez-Cintron W.;Saito S.;Soni N. J.;Noda J.;Hinojosa C. I.;Levine S. M.;Angel L. F.;Anzueto A.;Whitlow K. S.;Hipskind J.;Sukhija K.;Totten V.;Wunderink R. G.;Shah R. D.;Mateyo K. J.;Noriega L.;Alvarado E.;Aman M.;Labra L.
2020
Abstract
Background and objective: Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP. Methods: We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when ≥3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection. Results: Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP. Conclusion: This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.
Villafuerte, D., Aliberti, S., Soni, N., Faverio, P., Marcos, P., Wunderink, R., et al. (2020). Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. RESPIROLOGY, 25(5 (May 2020)), 543-551 [10.1111/resp.13663].
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/262298
Citazioni
31
28
Social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 598/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.
